Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein adipocyte-associated 1 (TPRA1), also known as GPR175, is an orphan G protein-coupled receptor (GPCR) encoded by the TPRA1 gene on chromosome 3[2][3][7][9]. It is predicted to be located primarily in the plasma membrane and is involved in G protein-coupled receptor (GPCR) signaling pathways[3][9][10]. TPRA1 has been linked to various biological processes, including the regulation of embryonic cleavage and negative control of mitotic cell cycle phase transitions[3][9]. Functional studies suggest that TPRA1 (GPR175) may play a modulatory role in signaling pathways such as the Hedgehog pathway by regulating cAMP levels[4]. Mutations or dysregulation of TPRA1 have been associated with rare diseases such as Fox-Fordyce disease and dyschromatosis universalis hereditaria[3]. As an orphan GPCR, no specific endogenous ligand is presently known, and there are no well-characterized drug interactions or established therapeutic agents targeting TPRA1 to date[3][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein adipocyte-associated 1 (TPRA1).